Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GEHC
stocks logo

GEHC

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
4.96B
+2.5%
0.918
-8.17%
5.03B
+3.34%
0.931
-18.31%
5.54B
+4.09%
1.177
-18.8%
Estimates Revision
The market is revising Upward the revenue expectations for GE HealthCare Technologies Inc. (GEHC) for FY2025, with the revenue forecasts being adjusted by 1.44% over the past three months. During the same period, the stock price has changed by -12.75%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.44%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-13.41%
In Past 3 Month
Stock Price
Go Down
down Image
-12.75%
In Past 3 Month
13 Analyst Rating
up Image0
Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is 84.69 USD with a low forecast of 73.00 USD and a high forecast of 95.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Buy
4 Hold
0 Sell
Moderate Buy
up Image0
Current: 71.890
sliders
Low
73.00
Averages
84.69
High
95.00
up Image0
Current: 71.890
sliders
Low
73.00
Averages
84.69
High
95.00
Goldman Sachs
David Roman
Hold
to
Strong Buy
Upgrades
$85 → $100
2025-03-11
Reason
Goldman Sachs
David Roman
Price Target
$85 → $100
2025-03-11
Upgrades
Hold
to
Strong Buy
Reason
Wells Fargo
Larry Biegelsen
Buy
Maintains
$96 → $103
2025-02-14
Reason
Wells Fargo
Larry Biegelsen
Price Target
$96 → $103
2025-02-14
Maintains
Buy
Reason
Citigroup
Joanne Wuensch
Strong Buy
Maintains
$103 → $110
2025-02-13
Reason
Citigroup
Joanne Wuensch
Price Target
$103 → $110
2025-02-13
Maintains
Strong Buy
Reason
Jefferies
Matthew Taylor
Hold
to
Strong Buy
Upgrades
$95 → $103
2025-01-08
Reason
Jefferies
Matthew Taylor
Price Target
$95 → $103
2025-01-08
Upgrades
Hold
to
Strong Buy
Reason
Wells Fargo
Larry Biegelsen
Buy
Maintains
$95 → $96
2024-10-31
Reason
Wells Fargo
Larry Biegelsen
Price Target
$95 → $96
2024-10-31
Maintains
Buy
Reason
Wells Fargo analyst Larry Biegelsen raised the firm's price target on GE HealthCare to $96 from $95 and keeps an Overweight rating on the shares. The firm notes GE HealthCare delivered organic growth of about 1%, while EPS beat consensus and Wells' estimates. Given China headwinds, management now sees lower end of 1%-2% organic growth in 2024. GE HealthCare sees the Flyrcado opportunity for revenues of over $500M annually, which the firm sees as encouraging.
Evercore ISI Group
Vijay Kumar
Buy
Maintains
$98 → $102
2024-10-01
Reason
Evercore ISI Group
Vijay Kumar
Price Target
$98 → $102
2024-10-01
Maintains
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for GE Healthcare Technologies Inc (GEHC.O) is 18.49, compared to its 5-year average forward P/E of 18.57. For a more detailed relative valuation and DCF analysis to assess GE Healthcare Technologies Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
18.57
Current PE
18.49
Overvalued PE
20.27
Undervalued PE
16.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
11.47
Current EV/EBITDA
11.79
Overvalued EV/EBITDA
13.18
Undervalued EV/EBITDA
9.77

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
1.76
Current PS
1.60
Overvalued PS
2.04
Undervalued PS
1.48

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 129.92% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

GEHC News & Events

Events Timeline

(ET)
2025-05-30
09:24:57
GE HealthCare announces NCCN Guidelines recommend use of FES PET imaging
select
2025-05-13 (ET)
2025-05-13
11:32:09
GE HealthCare sees revenue decline in Q2 'more' than Q1
select
2025-05-13
09:07:45
GE HealthCare gets FDA approval for Optison ultrasound enhancing agent
select
Sign Up For More Events
Sign Up For More Events

News

Preview
3.5
06-12Newsfilter
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions

  • GE HealthCare and MIM Encore Integration: GE HealthCare has launched its first combined software release with MIM Encore™, enhancing digital imaging and workflow solutions in oncology, cardiology, and neurology, aimed at improving efficiency and reducing manual workloads.

  • Enhanced Imaging Capabilities: The integration provides advanced features such as automated read preparation and high-quality image processing tools, enabling clinicians to deliver faster and more accurate diagnoses while streamlining workflows across departments.

Preview
8.0
06-07WSJ
China Is Putting Aside Its Self-Sufficiency Push for American Medicine

  • China's Economic Strategy: China is striving for economic self-sufficiency by reducing reliance on American technology, but it has made an exception for public health needs.

  • Healthcare Focus: To enhance its healthcare system to match that of wealthy nations by the decade's end, China continues to import American medical supplies and has exempted these goods from retaliatory tariffs.

Preview
3.0
06-03NASDAQ.COM
Noteworthy ETF Inflows: CGDV, CARR, LLY, GEHC

  • CGDV Share Price Analysis: CGDV's share price is currently at its 52-week high of $37.49, with a low point of $30.94, and comparisons to the 200-day moving average are suggested for technical analysis.

  • ETFs Trading Dynamics: ETFs function like stocks but trade in units that can be created or destroyed based on investor demand, impacting the underlying holdings significantly during notable inflows or outflows.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is GE Healthcare Technologies Inc (GEHC) stock price today?

The current price of GEHC is 71.89 USD — it has increased 1.05 % in the last trading day.

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s business?

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

arrow icon

What is the price predicton of GEHC Stock?

Wall Street analysts forecast GEHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GEHC is 84.69 USD with a low forecast of 73.00 USD and a high forecast of 95.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s revenue for the last quarter?

GE Healthcare Technologies Inc revenue for the last quarter amounts to 4.78B USD, increased 2.73 % YoY.

arrow icon

What is GE Healthcare Technologies Inc (GEHC)'s earnings per share (EPS) for the last quarter?

GE Healthcare Technologies Inc. EPS for the last quarter amounts to 1.23 USD, increased 51.85 % YoY.

arrow icon

What changes have occurred in the market's expectations for GE Healthcare Technologies Inc (GEHC)'s fundamentals?

The market is revising Upward the revenue expectations for GE HealthCare Technologies Inc. (GEHC) for FY2025, with the revenue forecasts being adjusted by 1.44% over the past three months. During the same period, the stock price has changed by -12.75%.
arrow icon

How many employees does GE Healthcare Technologies Inc (GEHC). have?

GE Healthcare Technologies Inc (GEHC) has 53000 emplpoyees as of June 20 2025.

arrow icon

What is GE Healthcare Technologies Inc (GEHC) market cap?

Today GEHC has the market capitalization of 32.92B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free